Suppr超能文献

玻璃体腔注射曲安奈德和贝伐单抗治疗成人科茨病严重黄斑水肿的疗效观察

Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.

作者信息

Jun Jong Hwa, Kim Yu Cheol, Kim Kwang Soo

机构信息

Department of Ophthalmology, School of Medicine, Dongsan Medical Center, Keimyung University, Daegu, Korea.

出版信息

Korean J Ophthalmol. 2008 Sep;22(3):190-3. doi: 10.3341/kjo.2008.22.3.190.

Abstract

A 47 year old male patient visited our hospital with the chief complaint of deterioration of the visual acuity in the left eye. The fundus examination revealed thick hard exudates, multiple aneurysms and telangiectasias of the retinal vessels in the posterior pole. Fluorescein angiography demonstrated massive leakage over an area of the aneurysms. Optical coherence tomography (Stratus OCT; Zeiss-Humphrey, Dubin, CA) revealed diffuse and marked thickening of the retina. Laser photocoagulation was performed under the diagnosis of Coats' disease. However, the treatment could not be performed satisfactorily. On the first and 6th weeks, an intravitreal injection of bevacizumab and triamcinolone acetonide was administered, and laser photocoagulation was again attempted. The effectiveness of eachagent on retinal edema was evaluated at the follow-up performed at 1, 2, 5, 7, 10 weeks and 6 months after the injection. At one week after the intravitreal bevacizumab injection, there was no improvement. An intravitreal injection of triamcinolone acetonide was performed 6 weeks after the initial diagnosis,which resulted in a reduction in the thickness of the macular edema. Therefore, laser photocoagulation was performed sufficiently on telangiectasias. The follow-up at 6 months showed a relative increase in the macular edema, but there was reduced leakage from the telangiectasias compared with the previous angiograph.

摘要

一名47岁男性患者因左眼视力下降为主诉前来我院就诊。眼底检查发现后极部视网膜有厚的硬性渗出物、多个动脉瘤及视网膜血管扩张。荧光素血管造影显示动脉瘤区域有大量渗漏。光学相干断层扫描(Stratus OCT;蔡司 - 汉弗莱,加利福尼亚州杜宾)显示视网膜弥漫性显著增厚。在诊断为科茨病后进行了激光光凝治疗。然而,治疗效果不理想。在第1周和第6周时,玻璃体内注射了贝伐单抗和曲安奈德,并再次尝试激光光凝治疗。在注射后1、2、5、7、10周及6个月的随访中评估了每种药物对视网膜水肿的疗效。玻璃体内注射贝伐单抗1周后,病情无改善。在初诊6周后进行了玻璃体内注射曲安奈德,导致黄斑水肿厚度降低。因此,对扩张血管充分进行了激光光凝治疗。6个月的随访显示黄斑水肿相对增加,但与之前的血管造影相比,扩张血管处的渗漏减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d173/2629899/2925e2a6a3ca/kjo-22-190-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验